183 related articles for article (PubMed ID: 15317744)
1. Antimycobacterial activity of synthetic pamamycins.
Lefèvre P; Peirs P; Braibant M; Fauville-Dufaux M; Vanhoof R; Huygen K; Wang XM; Pogell B; Wang Y; Fischer P; Metz P; Content J
J Antimicrob Chemother; 2004 Oct; 54(4):824-7. PubMed ID: 15317744
[TBL] [Abstract][Full Text] [Related]
2. The pamamycins: developmental autoregulators and antibiotics from Streptomyces alboniger. A review and update.
Pogell BM
Cell Mol Biol (Noisy-le-grand); 1998 May; 44(3):461-3. PubMed ID: 9620442
[TBL] [Abstract][Full Text] [Related]
3. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
[TBL] [Abstract][Full Text] [Related]
4. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
Taneja NK; Tyagi JS
J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
[TBL] [Abstract][Full Text] [Related]
5. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
Akselband Y; Cabral C; Shapiro DS; McGrath P
J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
Rai D; Johar M; Srivastav NC; Manning T; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2007 Sep; 50(19):4766-74. PubMed ID: 17696514
[TBL] [Abstract][Full Text] [Related]
7. [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria].
Zerbini E; Andreu D; Tonarelli G; Sequeira MD
Rev Argent Microbiol; 2006; 38(4):221-3. PubMed ID: 17370578
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465
[TBL] [Abstract][Full Text] [Related]
9. Trichoderins, novel aminolipopeptides from a marine sponge-derived Trichoderma sp., are active against dormant mycobacteria.
Pruksakorn P; Arai M; Kotoku N; Vilchèze C; Baughn AD; Moodley P; Jacobs WR; Kobayashi M
Bioorg Med Chem Lett; 2010 Jun; 20(12):3658-63. PubMed ID: 20483615
[TBL] [Abstract][Full Text] [Related]
10. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
Khan A; Sarkar S; Sarkar D
Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
[TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
12. A general sultone route to the pamamycin macrodiolides--total synthesis of pamamycin-621A and pamamycin-635B.
Fischer P; García Segovia AB; Gruner M; Metz P
Angew Chem Int Ed Engl; 2005 Sep; 44(38):6231-4. PubMed ID: 16145703
[No Abstract] [Full Text] [Related]
13. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
[TBL] [Abstract][Full Text] [Related]
14. A novel screening method based on menadione mediated rapid reduction of tetrazolium salt for testing of anti-mycobacterial agents.
Singh U; Akhtar S; Mishra A; Sarkar D
J Microbiol Methods; 2011 Feb; 84(2):202-7. PubMed ID: 21129420
[TBL] [Abstract][Full Text] [Related]
15. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis.
Parrish NM; Houston T; Jones PB; Townsend C; Dick JD
Antimicrob Agents Chemother; 2001 Apr; 45(4):1143-50. PubMed ID: 11257028
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity.
Barbachyn MR; Hutchinson DK; Brickner SJ; Cynamon MH; Kilburn JO; Klemens SP; Glickman SE; Grega KC; Hendges SK; Toops DS; Ford CW; Zurenko GE
J Med Chem; 1996 Feb; 39(3):680-5. PubMed ID: 8576910
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates.
Erturan Z; Uzun M
Int J Antimicrob Agents; 2005 Jul; 26(1):78-80. PubMed ID: 15950439
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria.
Carroll J; Draper LA; O'Connor PM; Coffey A; Hill C; Ross RP; Cotter PD; O'Mahony J
Int J Antimicrob Agents; 2010 Aug; 36(2):132-6. PubMed ID: 20547041
[TBL] [Abstract][Full Text] [Related]
20. Diversity-oriented synthesis of furo[3,2-f]chromanes with antimycobacterial activity.
Alvey L; Prado S; Saint-Joanis B; Michel S; Koch M; Cole ST; Tillequin F; Janin YL
Eur J Med Chem; 2009 Jun; 44(6):2497-505. PubMed ID: 19232450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
